Hope For Hepatitis C Patients

Monday, May 30, 2011 - 7:08am

Newly approved drugs could revolutionize treatment.

A new class of drugs could revolutionize the lives of Hepatitis C patients, nearly doubling the chance of a cure and, for many cutting treatment time in half.

Just approved by the FDA, the drugs short circuit the ability of the Hepatitis C virus to replicate, akin to the strategy used to combat HIV.

They're made by rivals Merck and biotech Vertex, and are expected to carry a hefty price tag.

Comments News Comments

Post new Comment